Stock Ratings / Consumer Discretionary / POM / financials

YJ (41) BQ (42) TKLF (54) WBUY (30) ⌘ Pro Terminal →

POMDOCTOR LIMITED (Class A) (POM) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$1.99 +10.56% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.02

POMDOCTOR LIMITED (Class A) (POM) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $5.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.02 (+1.71%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for POM)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (47/100 Composite)

🔍 WHY POM SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (30% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (28% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 54.1 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$0.77-18.2% Next Q

Q2 (-2Q)

Grade D$0.63+85.7% Next Q

Q3 (-1Q)

Grade D$1.17+70.1% Next Q

Current

Grade D$1.99-5.9% Hist 90D α

Trajectory: E (39) → D (47)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a POM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While POM currently carries a cautious 47/100 (D) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.98) and Max Pain ($2.09) forces dealer call-delta covering toward $121.53.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $POM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “POM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 47%NO 53%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How POM Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY25

Rev $57.2M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$57.2M	13.1%	-29.7%	$0	-$21.4M	-45%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring POM)

✓Walkthrough of POM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

POM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -70.91%📐 HORIZONTAL RANGE

2026-10-30O $1.72H $1.99L $1.30C $1.99VOL 717.2K

RES: $3.13SUP: $0.41SMA50: $0.98SMA200: $2.92

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

POM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 POM Butterfly Map → + Track POM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on POM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for POM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for POM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (POM)

Consumer Discretionary Rank #720 of 1011 ⚔️ YJ vs POM Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (POM vs. YJ, BQ, TKLF, WBUY)

Industry: Other Specialty Stores (42 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, POMDOCTOR LIMITED (Class A) (POM) ranks #720 by composite RQD confidence (47/100, grade D) and #964 by equity capitalization ($5.5M). Within this direct 5-issuer industry benchmark cohort, TKLF leads on earnings valuation at 11.9x trailing P/E, while YJ leads on capital efficiency and profitability with -13.7% ROIC and 44.4% gross margin. TKLF currently holds the highest overall quantitative score in the immediate peer group at 54/100 (D+) compared with POM at 47/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
POM ACTIVE POMDOCTOR LIMITED (Class A)	D	47/100	—	13.1%	-35.0%	+10.56%	$5.5M	Benchmark Subject
YJ Yunji Inc. American Depository Shares	D-	41/100	—	44.4%	-13.7%	-1.60%	$6.1M	/yj-vs-pom →
BQ Boqii Holding Limited (Class A)	D-	42/100	—	26.3%	—	-1.04%	$3.9M	/bq-vs-pom →
TKLF Tokyo Lifestyle Co. Ltd.	D+	54/100	11.9x	—	—	+8.51%	$8.5M	/tklf-vs-pom →
WBUY WEBUY GLOBAL LTD. (Class A)	E	30/100	—	12.0%	-35.0%	-3.58%	$3.3M	/wbuy-vs-pom →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001877971

In its most recent audited fiscal period (FY2025, filed 2025-12-31), POMDOCTOR LIMITED (Class A) (POM) reported GAAP revenue of $57.2M , GAAP net income of $0, operating cash flow of -$21.2M, and free cash flow of -$21.4M . On the balance sheet, POM closed FY2025 with $15.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$57.2M	$0	-$21.2M	-$21.4M	$15.4M	—

3. POM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is POM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, POMDOCTOR LIMITED (Class A) (NASDAQ: POM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.99 (+10.56% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, POM ranks #720 in composite RQD confidence.

How does POM compare to YJ and BQ in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Other Specialty Stores), POM carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of 13.1%, and ROIC of -35.0%. By comparison, YJ (Yunji Inc. American Depository Shares) holds a D- grade (41/100 RQD, P/E N/A, ROIC -13.7%, cap $6.1M) and BQ (Boqii Holding Limited (Class A)) posts a D- grade (42/100 RQD, P/E N/A, ROIC —, cap $3.9M). Among the 5-stock peer group, TKLF leads on earnings multiple (11.9x) while YJ leads on capital efficiency (-13.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for POM?

Per POM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001877971), POMDOCTOR LIMITED (Class A) generated $57.2M in revenue, $0 in net income, and -$21.4M in free cash flow against $15.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is POM trading relative to its 50-day, 200-day, and 52-week technical levels?

POM last traded at $1.99 (+10.56% on volume of 1,664,465 shares), positioning the stock +103.06% above its 50-day simple moving average ($0.98) and -31.85% below its 200-day simple moving average ($2.92). Across its 52-week range of $0.43 to $115.74, POM sits at the 1.4% percentile with a 14-day RSI of 54.1 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.74 to $2.24).

POM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is POMDOCTOR LIMITED (Class A) (POM)?

In FY 2025 (10-K), POM converted $57.2M of revenue into a 13.1% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

Direct Sub-Reports: POM RQD Cockpit POM 12M Forecast POM Earnings & Move POM Dividends & DRIP POM Insiders & 13F POM Whale Options POM Profit Sankey POM News & Why